Dubuque Bank & Trust CO Sage Therapeutics, Inc. Transaction History

Dubuque Bank & Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 14, 2020	SELL	$60.18 - $154.77 $96,288 - $247,632	-1,600 Closed	0 $0
Q2 2018 Jul 17, 2018	SELL	$140.36 - $175.76 $28,072 - $35,152	-200 Reduced 11.11%	1,600 $250,000
Q1 2018 May 10, 2018	SELL	$152.15 - $192.33 $1,521 - $1,923	-10 Reduced 0.55%	1,800 $290,000
Q4 2017 Feb 06, 2018	SELL	$60.72 - $167.34 $17,608 - $48,528	-290 Reduced 13.81%	1,810 $298,000
Q3 2017 Oct 13, 2017	BUY	$61.4 - $88.52 $128,940 - $185,892	2,100	2,100 $131,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Dubuque Bank & Trust CO with notifications on news.